David Raben

Insider Reports History

Location
Boston, MA
Signature
/s/ Lara Meisner, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Raben:

Company Role Class Num Shares Value Price $ Report Date Ownership
Bicara Therapeutics Inc. Chief Medical Officer Common Stock 55,286 $209,522 $3.79 26 Dec 2025 Direct
Bicara Therapeutics Inc. Chief Medical Officer Stock Option (Right to Buy) 100,000 02 Feb 2026 Direct

Insider Reports Filed by David Raben

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCAX Bicara Therapeutics Inc. 02 Feb 2026 1 $0 4 Chief Medical Officer 04 Feb 2026, 16:36
BCAX Bicara Therapeutics Inc. 26 Dec 2025 2 +$74,996 4 Chief Medical Officer 29 Dec 2025, 17:10
BCAX Bicara Therapeutics Inc. 24 Nov 2025 9 -$163,420 4 Chief Medical Officer 25 Nov 2025, 18:39
BCAX Bicara Therapeutics Inc. 09 Oct 2025 3 -$322,524 4 Chief Medical Officer 10 Oct 2025, 17:23
BCAX Bicara Therapeutics Inc. 12 Sep 2024 0 $0 3 Chief Medical Officer 12 Sep 2024, 21:15